289 related articles for article (PubMed ID: 30139841)
1. Patient-Clinician Discordance in Perceptions of Treatment Risks and Benefits in Older Patients with Acute Myeloid Leukemia.
El-Jawahri A; Nelson-Lowe M; VanDusen H; Traeger L; Abel GA; Greer JA; Fathi A; Steensma DP; LeBlanc TW; Li Z; DeAngelo D; Wadleigh M; Hobbs G; Foster J; Brunner A; Amrein P; Stone RM; Temel JS
Oncologist; 2019 Feb; 24(2):247-254. PubMed ID: 30139841
[TBL] [Abstract][Full Text] [Related]
2. Quality of life and mood of older patients with acute myeloid leukemia (AML) receiving intensive and non-intensive chemotherapy.
El-Jawahri A; Abel GA; Traeger L; Waldman L; Markovitz N; VanDusen H; Fathi A; Steensma DP; LeBlanc TW; Horick NK; DeAngelo DJ; Wadleigh M; Hobbs G; Foster J; Brunner AM; Amrein P; Stone RM; Temel JS; Greer JA
Leukemia; 2019 Oct; 33(10):2393-2402. PubMed ID: 30923318
[TBL] [Abstract][Full Text] [Related]
3. Decision-making and quality of life in older adults with acute myeloid leukemia or advanced myelodysplastic syndrome.
Sekeres MA; Stone RM; Zahrieh D; Neuberg D; Morrison V; De Angelo DJ; Galinsky I; Lee SJ
Leukemia; 2004 Apr; 18(4):809-16. PubMed ID: 14762444
[TBL] [Abstract][Full Text] [Related]
4. Using Social Media to Uncover Treatment Experiences and Decisions in Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome Who Are Ineligible for Intensive Chemotherapy: Patient-Centric Qualitative Data Analysis.
Booth A; Bell T; Halhol S; Pan S; Welch V; Merinopoulou E; Lambrelli D; Cox A
J Med Internet Res; 2019 Nov; 21(11):e14285. PubMed ID: 31755871
[TBL] [Abstract][Full Text] [Related]
5. The relationship between emotional well-being and understanding of prognosis in patients with acute myeloid leukemia (AML).
Singh A; Locke SC; Wolf SP; Albrecht TA; Troy JD; Derry H; El-Jawahri A; LeBlanc TW
Support Care Cancer; 2022 Jan; 30(1):897-906. PubMed ID: 34401981
[TBL] [Abstract][Full Text] [Related]
6. Are social inequalities in acute myeloid leukemia survival explained by differences in treatment utilization? Results from a French longitudinal observational study among older patients.
Berger E; Delpierre C; Despas F; Bertoli S; Bérard E; Bombarde O; Bories P; Sarry A; Laurent G; Récher C; Lamy S
BMC Cancer; 2019 Sep; 19(1):883. PubMed ID: 31488077
[TBL] [Abstract][Full Text] [Related]
7. Older patients' experiences following initial diagnosis of acute myeloid leukemia: A qualitative study.
Abdallah M; Kadambi S; Parsi M; Rai M; Mendler JH; Wittink M; Duberstein PR; Tsang M; Klepin HD; Loh KP
J Geriatr Oncol; 2022 Nov; 13(8):1230-1235. PubMed ID: 36064536
[TBL] [Abstract][Full Text] [Related]
8. Patient-centered communication tool for older patients with acute myeloid leukemia, their caregivers, and oncologists: A single-arm pilot study.
LoCastro M; Sanapala C; Wang Y; Jensen-Battaglia M; Wittink M; Norton S; Klepin HD; Richardson DR; Mendler JH; Liesveld J; Huselton E; O'Dwyer K; Cortes AM; Rodriguez C; Dale W; Loh KP
Cancer Med; 2023 Apr; 12(7):8581-8593. PubMed ID: 36533397
[TBL] [Abstract][Full Text] [Related]
9. Patient experiences of acute myeloid leukemia: A qualitative study about diagnosis, illness understanding, and treatment decision-making.
LeBlanc TW; Fish LJ; Bloom CT; El-Jawahri A; Davis DM; Locke SC; Steinhauser KE; Pollak KI
Psychooncology; 2017 Dec; 26(12):2063-2068. PubMed ID: 27862591
[TBL] [Abstract][Full Text] [Related]
10. Patient Perceptions of Treatment Benefit and Toxicity in Advanced Cancer: A Prospective Cross-Sectional Study.
Patell R; Einstein D; Miller E; Dodge L; Halleck J; Buss M
JCO Oncol Pract; 2021 Feb; 17(2):e119-e129. PubMed ID: 33444075
[TBL] [Abstract][Full Text] [Related]
11. Superior long-term outcome with idarubicin compared with high-dose daunorubicin in patients with acute myeloid leukemia age 50 years and older.
Gardin C; Chevret S; Pautas C; Turlure P; Raffoux E; Thomas X; Quesnel B; de Revel T; de Botton S; Gachard N; Renneville A; Boissel N; Preudhomme C; Terré C; Fenaux P; Bordessoule D; Celli-Lebras K; Castaigne S; Dombret H
J Clin Oncol; 2013 Jan; 31(3):321-7. PubMed ID: 23248249
[TBL] [Abstract][Full Text] [Related]
12. Patient preferences, regret, and health-related quality of life among older adults with acute myeloid leukemia: A pilot longitudinal study.
LoCastro M; Wang Y; Sanapala C; Jensen-Battaglia M; Wittink M; Norton S; Klepin HD; Richardson DR; Mendler JH; Liesveld J; Huselton E; Loh KP
J Geriatr Oncol; 2023 Jun; 14(5):101529. PubMed ID: 37244139
[TBL] [Abstract][Full Text] [Related]
13. Experiences of treatment decision-making among older newly diagnosed adults with acute myeloid leukemia: a qualitative descriptive study.
Richardson DR; Mhina CJ; Teal R; Cole AC; Adapa K; Bryant AL; Crossnohere N; Wheeler SC; Bridges JFP; Wood WA
Support Care Cancer; 2024 Feb; 32(3):197. PubMed ID: 38416230
[TBL] [Abstract][Full Text] [Related]
14. Patients' perception of the benefits of palliative systemic therapy for advanced cancer.
Subramaniam S; Adams DH; Tognela A; Roncolato F; Yip PY; Lim SH; Roohullah A; Stockler MR; Kiely B
Intern Med J; 2024 May; 54(5):735-741. PubMed ID: 38205872
[TBL] [Abstract][Full Text] [Related]
15. Patients' and family caregivers' understanding of the cancer stage, treatment goal, and chance of cure: A study with patient-caregiver-physician triad.
Shin DW; Cho J; Kim SY; Yang HK; Park K; Kweon SS; Koh DH; Nam HS; Park JH
Psychooncology; 2018 Jan; 27(1):106-113. PubMed ID: 28603876
[TBL] [Abstract][Full Text] [Related]
16. Multisite 11-year experience of less-intensive vs intensive therapies in acute myeloid leukemia.
Sorror ML; Storer BE; Fathi AT; Brunner A; Gerds AT; Sekeres MA; Mukherjee S; Medeiros BC; Wang ES; Vachhani P; Shami PJ; Peña E; Elsawy M; Adekola K; Luger S; Baer MR; Rizzieri D; Wildes TM; Koprivnikar J; Smith J; Garrison M; Kojouri K; Leisenring W; Onstad L; Nyland JE; Becker PS; McCune JS; Lee SJ; Sandmaier BM; Appelbaum FR; Estey EH
Blood; 2021 Aug; 138(5):387-400. PubMed ID: 34351368
[TBL] [Abstract][Full Text] [Related]
17. Analysis of Patient-Physician Concordance in the Understanding of Chemotherapy Treatment Plans Among Patients With Cancer.
Almalki H; Absi A; Alghamdi A; Alsalmi M; Khan M
JAMA Netw Open; 2020 Mar; 3(3):e200341. PubMed ID: 32125427
[TBL] [Abstract][Full Text] [Related]
18. Prevalence and Predictors of Physician-Patient Discordance in Prognostic Perceptions in Advanced Cancer.
van der Velden NCA; Han PKJ; van Laarhoven HWM; de Vos FYFL; Hendriks LEL; Burgers SA; Dingemans AC; van Haarst JMW; Dits J; Smets EMA; Henselmans I
Oncologist; 2023 Aug; 28(8):e653-e668. PubMed ID: 37159001
[TBL] [Abstract][Full Text] [Related]
19. Characteristics and outcomes of older patients with secondary acute myeloid leukemia according to treatment approach.
Boddu PC; Kantarjian HM; Ravandi F; Garcia-Manero G; Verstovsek S; Jabbour EJ; Takahashi K; Bhalla K; Konopleva M; DiNardo CD; Ohanian M; Pemmaraju N; Jain N; Pierce S; Wierda WG; Cortes JE; Kadia TM
Cancer; 2017 Aug; 123(16):3050-3060. PubMed ID: 28387922
[TBL] [Abstract][Full Text] [Related]
20. Clofarabine in the treatment of newly diagnosed acute myeloid leukemia in older adults.
Tran H; Yang D
Ann Pharmacother; 2012 Jan; 46(1):89-96. PubMed ID: 22170975
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
